(2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride

C176H247ClF5N25O19Si5 — CID 158728230

IUPAC(2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride
SMILESC#C[C@]1(CO)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O[Si](C)(C)C(C)(C)C.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O[Si](C)(C)C(C)(C)C.CCCCCCCCCCCCCC(=O)Cl
InChIInChI=1S/C48H70FN5O4Si2.C34H44FN5O3Si2.C28H30FN5O3Si.2C26H38FN5O4.C14H27ClO/c1-11-13-14-15-16-17-18-19-20-21-28-33-40(55)51-43-42-44(53-45(49)52-43)54(36-50-42)41-34-39(58-59(9,10)46(3,4)5)48(12-2,57-41)35-56-60(47(6,7)8,37-29-24-22-25-30-37)38-31-26-23-27-32-38;1-10-34(22-41-45(33(5,6)7,24-17-13-11-14-18-24)25-19-15-12-16-20-25)26(43-44(8,9)32(2,3)4)21-27(42-34)40-23-37-28-29(36)38-31(35)39-30(28)40;1-5-28(21(35)16-22(37-28)34-18-31-23-24(30)32-26(29)33-25(23)34)17-36-38(27(2,3)4,19-12-8-6-9-13-19)20-14-10-7-11-15-20;2*1-3-5-6-7-8-9-10-11-12-13-14-15-20(35)29-23-22-24(31-25(27)30-23)32(18-28-22)21-16-19(34)26(4-2,17-33)36-21;1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2,22-27,29-32,36,39,41H,11,13-21,28,33-35H2,1,3-10H3,(H,51,52,53,55);1,11-20,23,26-27H,21-22H2,2-9H3,(H2,36,38,39);1,6-15,18,21-22,35H,16-17H2,2-4H3,(H2,30,32,33);2*2,18-19,21,33-34H,3,5-17H2,1H3,(H,29,30,31,35);2-13H2,1H3/t39-,41+,48+;26-,27+,34+;21-,22+,28+;2*19-,21+,26+;/m00000./s1
InChIKeyIKTUPWQHXQXZPW-UHIHZFMISA-N
MW3287.94 g/mol
LogP33.40
Rot. Bonds77

About (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride

(2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride (PubChem CID 158728230) has the molecular formula C176H247ClF5N25O19Si5 and a molecular weight of 3287.94 g/mol. Its IUPAC name is (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride.

Molecular Properties

Compound Name(2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride
PubChem CID158728230
Molecular FormulaC176H247ClF5N25O19Si5
Molecular Weight3287.94 g/mol
Exact Mass3284.76
IUPAC Name(2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride
SMILESC#C[C@]1(CO)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O[Si](C)(C)C(C)(C)C.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O[Si](C)(C)C(C)(C)C.CCCCCCCCCCCCCC(=O)Cl
InChIInChI=1S/C48H70FN5O4Si2.C34H44FN5O3Si2.C28H30FN5O3Si.2C26H38FN5O4.C14H27ClO/c1-11-13-14-15-16-17-18-19-20-21-28-33-40(55)51-43-42-44(53-45(49)52-43)54(36-50-42)41-34-39(58-59(9,10)46(3,4)5)48(12-2,57-41)35-56-60(47(6,7)8,37-29-24-22-25-30-37)38-31-26-23-27-32-38;1-10-34(22-41-45(33(5,6)7,24-17-13-11-14-18-24)25-19-15-12-16-20-25)26(43-44(8,9)32(2,3)4)21-27(42-34)40-23-37-28-29(36)38-31(35)39-30(28)40;1-5-28(21(35)16-22(37-28)34-18-31-23-24(30)32-26(29)33-25(23)34)17-36-38(27(2,3)4,19-12-8-6-9-13-19)20-14-10-7-11-15-20;2*1-3-5-6-7-8-9-10-11-12-13-14-15-20(35)29-23-22-24(31-25(27)30-23)32(18-28-22)21-16-19(34)26(4-2,17-33)36-21;1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2,22-27,29-32,36,39,41H,11,13-21,28,33-35H2,1,3-10H3,(H,51,52,53,55);1,11-20,23,26-27H,21-22H2,2-9H3,(H2,36,38,39);1,6-15,18,21-22,35H,16-17H2,2-4H3,(H2,30,32,33);2*2,18-19,21,33-34H,3,5-17H2,1H3,(H,29,30,31,35);2-13H2,1H3/t39-,41+,48+;26-,27+,34+;21-,22+,28+;2*19-,21+,26+;/m00000./s1
InChIKeyIKTUPWQHXQXZPW-UHIHZFMISA-N
XLogP33.40
TPSA567.86 Ų
H-Bond Donors10
H-Bond Acceptors41
Rotatable Bonds77
Heavy Atoms231
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003287.94
LogP ≤ 533.40
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1041

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acid_halide', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride?
The IUPAC name of (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride (CID 158728230) is (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride.
What is the SMILES notation for (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride?
The canonical SMILES for (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride is C#C[C@]1(CO)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O[Si](C)(C)C(C)(C)C.C#C[C@]1(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[C@@H](n2cnc3c(NC(=O)CCCCCCCCCCCCC)nc(F)nc32)C[C@@H]1O[Si](C)(C)C(C)(C)C.CCCCCCCCCCCCCC(=O)Cl.
What is the InChIKey of (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride?
The InChIKey is IKTUPWQHXQXZPW-UHIHZFMISA-N. The full InChI is InChI=1S/C48H70FN5O4Si2.C34H44FN5O3Si2.C28H30FN5O3Si.2C26H38FN5O4.C14H27ClO/c1-11-13-14-15-16-17-18-19-20-21-28-33-40(55)51-43-42-44(53-45(49)52-43)54(36-50-42)41-34-39(58-59(9,10)46(3,4)5)48(12-2,57-41)35-56-60(47(6,7)8,37-29-24-22-25-30-37)38-31-26-23-27-32-38;1-10-34(22-41-45(33(5,6)7,24-17-13-11-14-18-24)25-19-15-12-16-20-25)26(43-44(8,9)32(2,3)4)21-27(42-34)40-23-37-28-29(36)38-31(35)39-30(28)40;1-5-28(21(35)16-22(37-28)34-18-31-23-24(30)32-26(29)33-25(23)34)17-36-38(27(2,3)4,19-12-8-6-9-13-19)20-14-10-7-11-15-20;2*1-3-5-6-7-8-9-10-11-12-13-14-15-20(35)29-23-22-24(31-25(27)30-23)32(18-28-22)21-16-19(34)26(4-2,17-33)36-21;1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2,22-27,29-32,36,39,41H,11,13-21,28,33-35H2,1,3-10H3,(H,51,52,53,55);1,11-20,23,26-27H,21-22H2,2-9H3,(H2,36,38,39);1,6-15,18,21-22,35H,16-17H2,2-4H3,(H2,30,32,33);2*2,18-19,21,33-34H,3,5-17H2,1H3,(H,29,30,31,35);2-13H2,1H3/t39-,41+,48+;26-,27+,34+;21-,22+,28+;2*19-,21+,26+;/m00000./s1.
What are the key properties of (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride?
(2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride has a molecular weight of 3287.94 g/mol, XLogP of 33.40, 77 rotatable bonds, 10 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,5R)-5-(6-amino-2-fluoropurin-9-yl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-2-ethynyloxolan-3-ol;9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-amine;N-[9-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-ethynyloxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide;bis(N-[9-[(2R,4S,5R)-5-ethynyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-fluoropurin-6-yl]tetradecanamide);tetradecanoyl chloride is sourced from PubChem (CID 158728230), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).